Sacituzumab govitecan
Product Specifications
CAS Number
1491917-83-9
Target
Antibody-Drug Conjugates (ADCs) |||TROP2
Related Pathways
Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related
Purity
0.984
Bioactivity
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HY-P87413 1 Each
Nicotinic Acetylcholine Receptor beta 2/CHRNB2 Antibody (YA7101, Mouse)
Ask
View Details 
R9400-04-ML405 100 µL
RSK 4 (RSK4, pp90RSK4, p90-RSK 6, Ribosomal Protein S6 Kinase alpha 6, RPS6KA6, S6K-alpha 6) (MaxLight 405) discontinued
Ask
View Details 